Providing HIV Treatment to Children Remains Difficult in Kenya
January 13, 2014
Inter Press Service: Many Kenyan Children Miss Out on Life-Saving Drugs
"Thanks to antiretroviral drugs, HIV-positive children can now live to adulthood. Yet a significant number of children living with HIV in Kenya will die due to delay in receiving antiretroviral drugs (ARVs), inconsistent use of ARVs or, simply, no ARVs. ... [A] UNICEF report lists several barriers to pediatric ART [antiretroviral therapy]. Among them are limited availability of fixed-dose ARV combinations, poor palatability of recommended drug formulations for infants, lack of technology to test HIV infection among children under 18 months and fewer ART options for children than for adults ..." (Gathigah, 1/10).
NPR Continues Profile of PEPFAR Successes, Challenges; Examines Treatment for Serodiscordant Couples in Kenya
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)